33 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
provisions aimed at prescription drugs. In response to Biden’s executive order, on September 9, 2021, the U.S. Department of Health and Human Services (“HHS … , in the United States, CMS, other divisions of HHS, the U.S. Department of Justice, and similar foreign, state, and local government authorities, regulate
6-K
OBSVF
ObsEva SA
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
,” with multiple provisions aimed at prescription drugs. In response to Biden’s executive order, on September 9, 2021, the U.S. Department of Health
6-K
OBSVF
ObsEva SA
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
. Department of Health and Human Services (“HHS”) finalized a regulation removing safe harbor protection for price reductions from pharmaceutical
6-K
EX-99.3
8nz9 gjbzs06ao
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K/A
EX-99.2
lw7yho1
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
ihx8y5f
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-1.1
0ngy50ypp1izk5gg
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
arszg2ln3 w9fa
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.1
ez10fripsjkhigsi5
7 Jul 20
Current report (foreign)
3:39pm
6-K
EX-99.2
x1tsftebo9 3z
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.1
a1r0mwd u70xhm4rqcsz
7 Aug 19
Current report (foreign)
7:21am